Product Information
CHOLESTYRAMINE LIGHT POWDER is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1698 per GM under NDC 68382052942. Its NADAC has been published 425 times since Jul 18, 2018.
FDA first approved this application on Apr 25, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 g/5.5g
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382052942
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CHOLESTYRAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA202902FDA Approved
4/25/2017
TE Code
AB
On Market Since
6/8/2017
Pharmacological Classes
Price Statistics
The NADAC for CHOLESTYRAMINE LIGHT POWDER has been published 425 times since Jul 18, 2018, and over the history we have for it it has declined 26.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1698 per GM |
|---|---|
| All-time high | $0.2595 (Aug 14, 2019) |
| All-time low | $0.1343 (Nov 20, 2024) |
| 52-week high | $0.1704 |
| 52-week low | $0.1471 |
| Median price | $0.1994 |
| Average price | $0.1967 |
| Largest weekly change | +42.1% (Sep 23, 2020) |
| Weeks tracked | 425 |
| Tracking since | Jul 18, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 46% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CHOLESTYRAMINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bile Acid Sequestrant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHOLESTYRAMINE LIGHT POWDER?
The current National Average Drug Acquisition Cost (NADAC) for CHOLESTYRAMINE LIGHT POWDER, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1698 per GM (NDC 68382052942), effective Sep 30, 2026.
How has the price of CHOLESTYRAMINE LIGHT POWDER changed over time?
Over the history we have for it, the NADAC for CHOLESTYRAMINE LIGHT POWDER has declined 26.6%. It has been tracked across 425 weekly CMS publications since Jul 18, 2018.
What are the highest and lowest recorded NADAC prices for CHOLESTYRAMINE LIGHT POWDER?
Since Jul 18, 2018, the NADAC for CHOLESTYRAMINE LIGHT POWDER has ranged from a low of $0.1343 (Nov 20, 2024) to a high of $0.2595 (Aug 14, 2019), with a median of $0.1994 per GM.
Are there cheaper alternatives to CHOLESTYRAMINE LIGHT POWDER?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHOLESTYRAMINE POWDER, is $0.0924 per GM — about 46% below CHOLESTYRAMINE LIGHT POWDER.
Who manufactures CHOLESTYRAMINE LIGHT POWDER?
CHOLESTYRAMINE LIGHT POWDER (NDC 68382052942) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.